id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-D-1301-0006,FDA,FDA-2020-D-1301,Q3C(R8) Impurities: Guidance for Residual Solvents; International Council for Harmonisation; Guidance for Industry; Availability,Notice,Notice of Availability,2021-12-13T05:00:00Z,2021,12,2021-12-13T05:00:00Z,,2021-12-13T14:32:26Z,2021-26889,0,0,0900006484ec09b9
FDA-2020-D-1301-0007,FDA,FDA-2020-D-1301,Q3C(R8) Impurities: Guidance for Residual Solvents; Guidance for Industry,Other,Guidance,2021-12-13T05:00:00Z,2021,12,2021-12-13T05:00:00Z,,2024-11-12T23:35:03Z,,1,0,0900006484ec1498